Lilly Invests Another $5.3B in Indiana Plant to Boost Tirzepatide Manufacturing
Pictured: Eli Lilly's headquarters in Indianapolis/iStock, jetcityimage Eli Lilly announced Friday that it is investing an additional $5.3 billion in its manufacturing site in Indiana to boost the capacity for producing tirzepatide, the active …